Samarkan (Plenary) Special Session
Date
Wed, Apr 11, 2018
Time
09:45 - 10:45
Location
Samarkan (Plenary)
Moderators
  • G. Matthews (Marietta, United States of America)
  • K. Zaslav (Richmond, United States of America)
Extended Abstract (for invited Faculty only) Others

18.2.1 - The ACI/MACI Story: What went Right & What Problems were Overcome? (ID 10283)

Presentation Number
18.2.1
Topic
Others
Lecture Time
09:45 - 10:05
Corresponding Author
  • K. Zaslav (Richmond, United States of America)
Authors
  • K. Zaslav (Richmond, United States of America)
Disclosure
I have in the past had a consulting relationship with Genzyme, Sanofi and Vericel.
Extended Abstract (for invited Faculty only) New Cartilage Technology

18.2.2 - Promising Technologies & Failed Translation (ID 10298)

Presentation Number
18.2.2
Topic
New Cartilage Technology
Lecture Time
10:05 - 10:25
Corresponding Author
  • S. Kili (Shrewsbury)
Authors
  • S. Kili (Shrewsbury)
Disclosure
GSK, Employee Xintela AB, Board Member CCRM, Board Member SCB, VP & Board Member
Extended Abstract (for invited Faculty only) Others

18.2.3 - From Bench to Bedside: Cartilage Autograft Implant System (ID 10247)

Presentation Number
18.2.3
Topic
Others
Lecture Time
10:25 - 10:45
Corresponding Author
  • J. Farr (Greenwood, United States of America)
Authors
  • J. Farr (Greenwood, United States of America)
Disclosure
All disclosures up-to-date at AAOS.org